Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA041165-05
Application #
3181442
Study Section
Experimental Immunology Study Section (EI)
Project Start
1990-02-01
Project End
1994-06-30
Budget Start
1990-02-01
Budget End
1990-06-30
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Grigorieva, I; Grigoriev, V G; Rowney, M K et al. (2000) Regulation of c-myc transcription by interleukin-2 (IL-2). Identification of a novel IL-2 response element interacting with STAT-4. J Biol Chem 275:7343-50
Hoover, R G; Lary, C; Page, R et al. (1995) Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16. J Clin Invest 95:241-7
Epstein, J; Hoover, R; Kornbluth, J et al. (1995) Biological aspects of multiple myeloma. Baillieres Clin Haematol 8:721-34
Moore, J S; Hoover, R G (1989) Defective isotype-specific regulation of IgA anti-erythrocyte autoantibody-forming cells in NZB mice. J Immunol 142:4282-8
Moore, J S; Prystowsky, M B; Hoover, R G et al. (1988) Defective T cell-mediated, isotype-specific immunoglobulin regulation in B cell chronic lymphocytic leukemia. Blood 71:1012-20
Kornbluth, J; Hoover, R G (1988) Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function. J Immunol 141:3234-40
Roman, S; Moore, J S; Darby, C et al. (1988) Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor. J Immunol 140:3622-30
Sukhatme, V P; Kartha, S; Toback, F G et al. (1987) A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1:343-55
Broome, H E; Reed, J C; Godillot, E P et al. (1987) Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes. Mol Cell Biol 7:2988-93